Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 362 of 5804
-
Gut bacteria may supercharge lung cancer therapy
Disease control Recruiting nowThe goal of this clinical trial is to understand whether Lactobacillus rhamnosus LR607 can enhance neoadjuvant chemoimmunotherapy for adult patients with non-small cell lung cancer. It will also evaluate the safety of LR607. The main questions it aims to answer include: Can LR60…
Phase: PHASE2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could less radiation be better for HPV throat cancer?
Disease control Recruiting nowThis clinical trial evaluates how decreasing the dose of radiation to the elective neck (areas of lymph nodes not directly involved in the cancer) impacts treatment outcomes in patients with human papillomavirus (HPV)-related oropharyngeal cancer. Radiation therapy uses high ener…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could taking drug holidays improve CLL treatment?
Disease control Recruiting nowThis is a randomized Phase II study of intermittent versus continuous venetoclax therapy with Acalabrutinib in previously untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Phase: PHASE2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Radiation to the gut boosts cancer-killing power of immunotherapy in esophageal cancer trial
Disease control Recruiting nowEsophageal cancer (EC) ranks among the leading malignant gastrointestinal tumors globally in terms of both incidence and mortality. Cases of EC in China account for over 50% of the global total, with squamous cell carcinoma being the primary pathological type. Locally advanced EC…
Phase: PHASE2 • Sponsor: Chuangzhen Chen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for UC patients: early biologic treatment may beat standard therapy
Disease control Recruiting nowThe MIRACLE trial is for patients who have been newly diagnosed with moderate to severe ulcerative colitis in the last 12 months and who have not responded adequately to treatment with mesalazine and prednisolone alone. The standard drug therapy for ulcerative colitis begins with…
Phase: PHASE4 • Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New ultrasound technique aims to save limbs in artery disease patients
Disease control Recruiting nowThe purpose of this study is to determine if IVUS use, as compared to angiography alone, prevent major adverse limb events (MALE) or binary restenosis (a greater than 50% re-narrowing of the treated artery) in adult patients who have CLTI and are undergoing percutaneous revascula…
Phase: NA • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for tough blood cancers: experimental drug targets CD70
Disease control Recruiting nowThis is a single-arm, open-label, multicenter, dose-escalation, dose-expansion and efficacy-expansion phase I clinical study to evaluate the tolerability, safety, pharmacokinetics and preliminary antitumor activity of QLS2309 injection in patients with CD70+ relapsed/refractory h…
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New prostate cancer pill could rival current standard treatment
Disease control Recruiting nowThis study aims to compare the efficacy and safety of rezvilutamide with enzalutamide in the treatment of patients with low-volume metastatic hormone sensitive prostate cancer.
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New mRNA vaccine takes on advanced cancers in early trial
Disease control Not yet recruitingThis is an Investigator-initiated, Open-Label Clinical Study of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination with anti-PD-1 monoclonal antibody in Patients with Advanced Solid Tumors. Preclinical studies of this project have identified that circFAM5…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug targets Parkinson's protein in first human test
Disease control Recruiting nowThis study is researching an experimental drug called ALN-SNCA (called "study drug"). The study is focused on people with early Parkinson's disease, a disorder of the nervous system that affects movement. Parkinson's disease is caused by a gradual loss of nerve cells in the brain…
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a drug calm brain inflammation after stroke? new trial aims to find out
Disease control OngoingThis study is a randomized, double-blind, placebo-controlled clinical trial. Investigators aim to assess the efficacy and safety of interleukin-6 receptor inhibitor combined with endovascular treatment in patients with acute anterior circulation large vessel occlusion stroke.
Phase: PHASE3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New shot for wet AMD aims to save sight
Disease control Recruiting nowThis study is designed for Open-label, multi-center, single-arm Phase II trail to evaluate the efficacy and safety of intravitreal injection of IBI302 in nAMD patients.
Phase: PHASE2 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Donor cells take on Drug-Resistant viruses in new trial
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of Multi-Virus Specific T cells (LB-DTK-MV) to treat patients diagnosed with antiviral-resistant CMV, BKV, or EBV infection or associated diseases after anticancer therapy or allogeneic hematopoietic stem cell…
Phase: PHASE1, PHASE2 • Sponsor: LucasBio • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a headband ease endometriosis pain? new study tests At-Home brain zaps
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a wearable brain stimulation device called NettleEndo can reduce chronic pelvic pain and improve wellbeing in women with endometriosis. The study also aims to assess the safety and usability of the device when used at home over sever…
Phase: NA • Sponsor: Samphire Group, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New hope for Hard-to-Treat cancers: targeted drug combo enters phase 2 trial
Disease control Recruiting nowResearchers want to learn if calderasib given alone or with cetuximab can treat certain advanced solid tumors in people with the KRAS G12C mutation. The goals of this study are to learn: * How many people have the cancer respond (get smaller or go away) to calderasib alone or w…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New dressing may speed healing of diabetic foot wounds
Disease control Recruiting nowThis study aims to compare two treatment approaches for diabetic foot ulcers (DFUs): the standard of care (SOC) alone versus SOC combined with OCM. Researchers will evaluate whether adding OCM increases the likelihood of ulcers healing completely by the end of the trial period.
Phase: NA • Sponsor: Omeza, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail hopes to tackle tough lung cancer
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, safety, and ORR of HRS-4508 combined with other antitumor therapies in subjects with locally advanced or metastatic non-small cell lung cancer; Evaluate the pharmacokinetic (PK) characteristics of HRS-4508 and other efficacy …
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pill could clear skin in kids with psoriasis – trial underway
Disease control Recruiting nowThe main aim of this study is to see how well the medicine zasocitinib works, how safe it is, and how children and teenagers aged 4 to under 18 with moderate-to-severe plaque psoriasis respond to it. The study will be done in 2 parts: Part A will include both children and teenag…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New virus therapy takes on tough bladder cancer
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of Cretostimogene in patients with BCG-unresponsive high-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without Ta/T1 papillary tumors.
Phase: PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood cancer patients needed for flu vaccine showdown
⭐️ VACCINE ⭐️ Recruiting nowThis randomized controlled trial evaluates and compares the immunogenicity of three different influenza vaccine formulations: high-dose trivalent (HD-IIV3), MF59-adjuvanted quadrivalent (aIIV4), and standard-dose trivalent (SD-IIV3) vaccines. The study population consists of pati…
Phase: PHASE3 • Sponsor: Asan Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC